These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 20818153)
1. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease? Puri R; Ganesh S Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153 [TBL] [Abstract][Full Text] [Related]
2. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711 [TBL] [Abstract][Full Text] [Related]
3. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease. Puri R; Suzuki T; Yamakawa K; Ganesh S Hum Mol Genet; 2012 Jan; 21(1):175-84. PubMed ID: 21965301 [TBL] [Abstract][Full Text] [Related]
4. The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease. Gayarre J; Duran-Trío L; Criado Garcia O; Aguado C; Juana-López L; Crespo I; Knecht E; Bovolenta P; Rodríguez de Córdoba S Brain; 2014 Mar; 137(Pt 3):806-18. PubMed ID: 24430976 [TBL] [Abstract][Full Text] [Related]
5. Glycogen hyperphosphorylation underlies lafora body formation. Turnbull J; Wang P; Girard JM; Ruggieri A; Wang TJ; Draginov AG; Kameka AP; Pencea N; Zhao X; Ackerley CA; Minassian BA Ann Neurol; 2010 Dec; 68(6):925-33. PubMed ID: 21077101 [TBL] [Abstract][Full Text] [Related]
6. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models. Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983 [TBL] [Abstract][Full Text] [Related]
7. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells. Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008 [TBL] [Abstract][Full Text] [Related]
8. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway. Upadhyay M; Gupta S; Bhadauriya P; Ganesh S Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034 [TBL] [Abstract][Full Text] [Related]
9. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease. Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944 [TBL] [Abstract][Full Text] [Related]
10. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656 [TBL] [Abstract][Full Text] [Related]
11. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304 [TBL] [Abstract][Full Text] [Related]
12. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease. Rai A; Mishra R; Ganesh S Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665 [TBL] [Abstract][Full Text] [Related]
13. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase. Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease. Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957 [TBL] [Abstract][Full Text] [Related]
15. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration. Spuch C; Ortolano S; Navarro C Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717 [TBL] [Abstract][Full Text] [Related]
16. Lafora disease: Current biology and therapeutic approaches. Mitra S; Gumusgoz E; Minassian BA Rev Neurol (Paris); 2022 Apr; 178(4):315-325. PubMed ID: 34301405 [TBL] [Abstract][Full Text] [Related]
17. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin. DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597 [TBL] [Abstract][Full Text] [Related]
18. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease. Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032 [TBL] [Abstract][Full Text] [Related]
19. Impaired malin expression and interaction with partner proteins in Lafora disease. Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion. Chambers JK; Thongtharb A; Shiga T; Azakami D; Saito M; Sato M; Morozumi M; Nakayama H; Uchida K Vet Pathol; 2018 Jul; 55(4):543-551. PubMed ID: 29444631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]